Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Auditor change
Appointed director
NeuroMetrix, Inc. (NURO)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
04/22/2021
GN
NeuroMetrix Reports Q1 2021 Financial Results
01/28/2021
GN
NeuroMetrix Reports Q4 and Full Year 2020 Financial Results
01/22/2021
GN
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call
10/22/2020
GN
NeuroMetrix Reports Q3 2020 Financial Results
10/15/2020
GN
NeuroMetrix, Inc. Announces Date for Third Quarter 2020 Financial Results Conference Call
09/22/2020
GN
NeuroMetrix Launches Quell® App for Apple Watch®, the First Smartwatch App for an Over-the-Counter Pain Relief Device
09/21/2020
GN
NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology
09/04/2020
GN
NeuroMetrix Reports Scientific Presentation at the PAINWeek 2020 Live Virtual Conference
09/01/2020
GN
NeuroMetrix Reports Publication of Study Validating DPNCheck® Staging of Diabetic Peripheral Neuropathy Severity
08/20/2020
GN
NeuroMetrix Reports that Quell® is to be Evaluated for Chemotherapy-Induced Peripheral Neuropathy in NIH-Funded Clinical Trial
08/10/2020
GN
Quell® Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
07/23/2020
GN
NeuroMetrix Reports Q2 2020 Financial Results
07/16/2020
GN
NeuroMetrix, Inc. Announces Date for Second Quarter 2020 Financial Results Conference Call
06/25/2020
GN
NeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
06/10/2020
GN
NeuroMetrix to Target Chronic Knee Pain with Quell® 2.0 Wearable Pain Relief Device
04/23/2020
GN
NeuroMetrix Reports Q1 2020 Financial Results
04/16/2020
GN
NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia
04/16/2020
GN
NeuroMetrix, Inc. Announces Date for First Quarter 2020 Financial Results Conference Call
04/10/2020
GN
NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only
03/11/2020
GN
NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update
03/05/2020
GN
NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®
02/25/2020
GN
NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting
01/27/2020
GN
NeuroMetrix Reports Q4 and Full Year 2019 Financial Results
01/17/2020
GN
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call
11/18/2019
GN
NeuroMetrix Announces One-for-Ten Reverse Split
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy